Search Site

Steven J. Lobritto, MD

  • Associate Professor of Pediatrics at CUMC
  • Associate Professor of Medicine at CUMC
  • Medical Director, Pediatric Liver Transplantation, NewYork-Presbyterian/Columbia
Steven J. Lobritto, MD

Education & Training

  • New York Medical College, NY
  • MD, 1988 New York Medical College
  • Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Honors & Awards

  • Alpha Omega Alpha Medical Honor Society

Research Interests

  • Hepatitis B and C treatment in children
  • Non-alcoholic related fatty liver disease
  • Novel immunosuppression approaches in pediatric liver transplantation
  • Treatment and management of intestinal failure induced liver injury

NIH Grants

  • AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF GLECAPREVIR/PIBRENTASVIR IN PEDIATRIC SUBJECTS WITH GENOTYPES 1AND 6 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION (P&S Industry Clinical Trial)

    Jun 6 2017 - Jun 6 2022

    DE NOVO AUTOIMMUNE HEPATITIS IN PEDIATRIC LIVER TRANSPLANT (Private)

    Aug 1 2016 - Jul 31 2018

    A TWO-PART, OPEN-LABEL, SINGEL-ARM PHASE 1/2 STUDY OF SAFETY, PHARMACOKINETICS AND EFFICACY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN IN PEDIATRIC SUBJECTS AGED 3 TO 17 INFECTED WITH GENOTYPE 1 HEPATITIS C VIRUS (P&S Industry Clinical Trial)

    Nov 5 2012 - Nov 5 2017

    IMMUNOSUPRESSION WITHDRAWL FOR STABLE PEDIATRIC LIVER T (Federal Gov)

    Jul 27 2012 - Jun 30 2017

    A RANDOMIZED MULTICENTER, PHASE III STUDY EVALUATING THE EFF ICACY AND SAFETY OF PEGINTERFERON ALFA-2 (Private)

    Oct 1 2011 - Mar 15 2013

    AN OBSERVATIONAL STUDY OF THE CLINICAL CHARACTERISTICS AND DISEASE PROGRESSION OF PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY/CHOLESTERYL ESTER STORAGE DISEASE PHENOTYPE (Private)

    Dec 20 2011 - Dec 19 2012

    IMMUNOSUPPRESSION WITHDRAWAL FOR STABLE PEDIATRIC LIVER TRAN SPLANT RECIPIENTS (Federal Gov)

    Sep 1 2011 - Mar 31 2012

    A MULTI-CENTER GROUP TO STUDY ACCUTE LIVER FAILURE IN CHILDR EN (Federal Gov)

    Sep 1 2009 - Aug 31 2010

    A MULTI-CENTER TRIAL OF STUDY ACUTE LIVER FAILURE--DATA AND SPECIMEN COLLECTION (Federal Gov)

    Sep 1 2005 - Aug 31 2010

    PEGYLATED INTERFERON +/- RIBAVIRIN FOR CHILDREN WITH HCV PED S C (Federal Gov)

    Sep 1 2003 - Aug 31 2010

    STUDIES OF PEDIATRIC LIVER TRANSPLANTATION(SPLIT) A MILTI- CENTER, PROSPECTIVE STUDY TO COLLECT DATA (Federal Gov)

    Jun 1 2004 - Mar 31 2008

    A MULTI-CENTER TRIAL TO STUDY ACUTE LIVER FAILURE (Federal Gov)

    Sep 1 2002 - Aug 31 2005

Publications

  • Salame E, Goldstein MJ, Kinkhabwala M, Kapur S, Finn R, Lobritto S, Brown R Jr., Emond JC: Model for end stage liver disease and Child-Turcotte-Pugh scores as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl. 2002, March 8(3):278-84
  • Nasr SH, Lobritto SJ, Lauring BP, Arend LJ< D’agati VD, Markowitz,GS: A rare complicationof monoclonalgammopathy. AM J Kidney Dis. 2002 Oct. 40(4):867-71.
  • Robert S. Brown, Jr., K. Shiva Kumar, Mark W. Russo, Milan Kinkhabwala, Diane L. Rudow, Patricia Harren, Steven J. Lobritto, Jean C. Emond: Model for End Stage Liver Disease and Child-Turcotte-Pugh Score as Predictors of Pretransplantation Disease Severity, Postransplantation Outcome, and Resource Utilization in United Network for Organ Sharing Status 2A Patients. Liver Transplantation, Vol 8, No3 (March), 2002: pp 278-284

For a complete list of publications, please visit PubMed.gov